Up­dat­ed: FDA ex­pands la­bel for nasal spray to treat chron­ic si­nus in­flam­ma­tion

Last year
Pharma
FDA+

Ap­peals court re­vers­es No­var­tis win over Re­gen­eron in Eylea-Lu­cen­tis bat­tle

Last year
Pharma
Law

FDA green­lights Or­chard's gene ther­a­py Len­meldy for rare and fa­tal dis­ease

Last year
Pharma
Cell/Gene Tx

Ex­act Sci­ences us­es March Mad­ness cam­paign to dri­ve colon can­cer screen­ing

Last year
Pharma
Marketing

WuXi AppTec's 2023 sales large­ly re­liant on the US, re­port says

Last year
China
Manufacturing

As­traZeneca joins Boehringer In­gel­heim in cap­ping out-of-pock­et in­haler costs at $35

Last year
Pharma

Mer­ck’s six-year deal strat­e­gy could de­liv­er a block­buster if hy­per­ten­sion drug is OK’d this month

Last year
Deals

Abeona’s new Form 483 is an­oth­er man­u­fac­tur­ing set­back for its rare skin con­di­tion as­set

Last year
Manufacturing

Blue­bird's $175M loan; Spyre re­veals sec­ond pri­vate place­ment

Last year
News Briefing

In­tro­duc­ing Post-Hoc: Our lat­est newslet­ter with analy­sis and in­sights

Last year
Editor's note

Health tech uni­corn Col­or Health push­es deep­er in­to can­cer care

Last year
Health Tech

Pfiz­er sells off par­tial stake in Ha­le­on, po­ten­tial­ly rais­ing $2B+

Last year
Deals
Pharma

GSK’s new PhI­II da­ta sup­port bid for wider en­dome­tri­al can­cer la­bel for Jem­per­li

Last year
R&D
Pharma

WuXi fall­out re­ver­ber­ates; Phar­ma's top R&D spenders; Lil­ly teams up with Ama­zon; His­toric NASH ap­proval; and more

Last year
Weekly

Con­tineum Ther­a­peu­tics files for IPO with MS drug in PhII

Last year
Financing
Startups

Up­dat­ed: FDA ad­comm backs ben­e­fits of Abec­ma and Carvyk­ti in ear­li­er pa­tients

Last year
Pharma
FDA+

Mod­er­na turns the spot­light on long Covid with new ini­tia­tives

Last year
Pharma
Coronavirus

Bris­tol My­ers scores ac­cel­er­at­ed ap­proval in more blood can­cers for CAR-T ther­a­py Breyanzi

Last year
Pharma
Cell/Gene Tx

FDA lays out cross-agency ef­forts on reg­u­lat­ing AI in med­ical prod­ucts

Last year
AI
Pharma

It takes GUTS to be BOLD: A look at the new biotech tick­ers

Last year
Startups

Bio­theus builds on ADC pact with Han­soh; No­var­tis ex­pands in Sin­ga­pore; Astel­las leaves Carte­sian deal

Last year
News Briefing

From the news­room: End­points wins a SABEW award for gen­er­al ex­cel­lence

Last year
Editor's note

Bio­gen los­es CMO, neu­ro­mus­cu­lar leader; John Hood adds pres­i­dent, CFO at En­deav­or Bio­Med­i­cines

Last year
People
Peer Review

Eu­roAPI halts pro­duc­tion at Ital­ian site as qual­i­ty con­trol is­sues due to ‘po­ten­tial’ mis­con­duct come to light

Last year
Manufacturing
First page Previous page 184185186187188189190 Next page Last page
A service from the Financial Times